The optima stroke product was developed to avert strokes through preventive medicine
Strokes occur in all age groups, and their incidence doubles every 10 years after the age of 55.
One in four people aged over 25 will have a stroke in their lifetime.
Stroke is an immense economic burden on healthcare systems.
There are over 15 million new cases of stroke globally each year.
The clinical purpose of the product is to identify patients with calcification in their carotid arteries. This calcification is a sign of atherosclerosis (plaque buildup in arteries), and therefore has two important clinical implications:
Wang, X., Chen, X., Chen, Z., & Zhang, M. (2022). Arterial calcification and its association with stroke: implication of risk, prognosis, treatment response, and prevention. Frontiers in Cellular Neuroscience, 16, 845215.
Optima Stroke will be implemented through dental clinics associated with public and private healthcare systems. Optima Stroke works continuously and automatically in the background, analyzing every panoramic x-ray taken, and immediately notifies the appropriate healthcare giver when a patient is identified as being of risk of having a stroke.